Clinical Trial Update: Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing temozolomide to the PCV regimen (procarbazine, lomustine, and vincristine) in patients with recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Lomustine (Lomustine)
• Procarbazine (procarbazine)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Brain and Central Nervous System Tumors | Phase 3 | Status: COMPLETED